Reinventing Drug Discovery, from Retrospective to Perspectives

10th NovAliX Conference - Anniversary Edition

 Brunnen, Switzerland    June 2-4, 2024

Vision for the Future of Drug Discovery

Dr Claude BERTRAND
INSTITUT DE RECHERCHES SERVIER, Paris, France

Dr Karin BRINER
GENENTECH, South San Francisco, United States

Dr Harren JHOTI
ASTEX PHARMACEUTICALS, Cambridge, United Kingdom

Dr Paul STOFFELS
GALAPAGOS, Beerse, Belgium

Present and Future Tools for Drug Discovery

Prof. Cheryl ARROWSMITH
STRUCTURAL GENOMICS CONSORTIUM, Toronto, Canada

Dr Maria M. FLOCCO
ASTRAZENECA, Cambridge, United Kingdom

Prof. Andrew HOPKINS
EXSCIENTIA, Oxford, United Kingdom

Prof. Holger STARK
MAX PLANCK INSTITUTE FOR MULTIDISCIPLINARY SCIENCES, Göttingen, Germany

New Modalities as New Frontiers of Drug Discovery

Prof. Alessio CIULLI
UNIVERSITY OF DUNDEE, Dundee, United Kingdom

Dr Robert COPELAND
ACCENT THERAPEUTICS, INC., Lexington, United States

Prof. Craig CREWS
YALE UNIVERSITY, New Haven, CT, United States

Unmet Therapeutic Needs : Current Challenges

Dr Erin DUFFY
CARB-X, Boston, United States

Dr Tobias SCHMELZLE
NOVARTIS, Basel, Switzerland

Round table Contributors

Dr Chun-wa CHUNG
GLAXOSMITHKLINE, Stevenage, United Kingdom

Prof. Helena DANIELSON
UPPSALA UNIVERSITY, Uppsala, Sweden

Dr Matthias FRECH
MERCK, Darmstadt, Germany

Dr Stefan GESCHWINDNER
ASTRAZENECA, Mölndal, Sweden

Dr Sylwia HUBER
F. HOFFMANN-LA ROCHE, Basel, Switzerland

Dr Sandra JACOB
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland

Dr Herbert NAR
BOEHRINGER INGELHEIM, Biberach, Germany

Printer friendly version